AstraZeneca CEO says lung cancer drug trial data 'very encouraging'

AstraZeneca Chief Executive Pascal Soriot said on Friday the company is "very encouraged" by interim data from a key lung cancer drug trial, but he did not explain why the company had not declared results as "clinically meaningful". The drugmaker's shares fell by as much as 8% earlier this month…

#pascalsoriot #tropion